4.7 Article Proceedings Paper

Angiotensin-converting enzyme 2 and angiotensin-(1-7) - An evolving story in cardiovascular regulation

Journal

HYPERTENSION
Volume 47, Issue 3, Pages 515-521

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/01.HYP.0000196268.08909.fb

Keywords

hypertension; receptors, angiotensin; angiotensin converting enzyme; angiotensin II

Funding

  1. NHLBI NIH HHS [HL-51952, HL-6835] Funding Source: Medline

Ask authors/readers for more resources

This lecture summarizes the chronology and rationale that led to the discovery of angiotensin-(1-7) as a hormone that, in its own right, opposes the vasoconstrictor and proliferative actions of angiotensin II. The work discussed here additionally analyzes the newest findings on angiotensin- converting enzyme 2, the angiotensin- converting enzyme homologue that efficiently hydrolyzes angiotensin II into angiotensin-(1-7). Both components of this system may significantly influence our future perspective of the role of the renin-angiotensin system, not just in terms of its role in the regulation of cardiovascular and renal function but, moreover, as regulators of a vast array of disease processes in which inflammation and immune mechanisms play a role.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available